T
Thomas Glück
Researcher at University of Regensburg
Publications - 62
Citations - 2062
Thomas Glück is an academic researcher from University of Regensburg. The author has contributed to research in topics: Sepsis & Intensive care. The author has an hindex of 23, co-authored 61 publications receiving 1836 citations. Previous affiliations of Thomas Glück include University Hospital Regensburg.
Papers
More filters
Journal ArticleDOI
Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients
Wolfgang Drobnik,Gerhard Liebisch,Franz-Xaver Audebert,D. Fröhlich,Thomas Glück,Peter Vogel,Gregor Rothe,Gerd Schmitz +7 more
TL;DR: The increased Cer-SPM ratios as well as the decreased LPC-PC ratios showed a strong predictive power for sepsis-related mortality, providing the first ex vivo indication for the role of Cer and lysophospholipids in systemic inflammation in humans.
Journal Article
Immune status and risk for infection in patients receiving chronic immunosuppressive therapy.
Thomas Glück,Bernhard Kiefmann,Mathias Grohmann,Werner Falk,Rainer H. Straub,Jürgen Schölmerich +5 more
TL;DR: Investigating the effects of commonly used immunosuppressive treatment regimens on lymphocyte subsets and cytokine release from stimulated whole blood cultures in patients with rheumatic or autoimmune diseases found that T-helper cell counts may be useful to estimate the risk for subsequent infections in such patients.
Journal ArticleDOI
Successful containment of COVID-19: the WHO-Report on the COVID-19 outbreak in China.
TL;DR: A WHO mission has visited China and Wuhan and corroborated the outbreak dynamic and case count reported by the Chinese government, and the Chinese success‐estimating an upper limit to the attack rate in Hubei province.
Journal ArticleDOI
A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization.
David Peterhoff,Vivian Glück,Matthias Vogel,Philipp Schuster,Anja Schütz,P Neubert,Veruschka Albert,Stefanie Frisch,Mara Kiessling,Philip Pervan,Maren Werner,Nicole Ritter,Leon Babl,Maria Deichner,Frank Hanses,Matthias Lubnow,Thomas Müller,Dirk Lunz,Florian Hitzenbichler,Franz Audebert,Viola Hähnel,Robert Offner,Martina Müller,S Schmid,Ralph Burkhardt,Thomas Glück,Michael Koller,Hans Helmut Niller,Bernhard M. Graf,Bernd Salzberger,Jürgen J. Wenzel,Jonathan Jantsch,Jonathan Jantsch,André Gessner,André Gessner,Barbara Schmidt,Barbara Schmidt,Ralf Wagner,Ralf Wagner +38 more
TL;DR: Due to high specificity and strong correlation with virus neutralization, the RBD ELISA holds great potential to become a preferred tool to assess thresholds of protective immunity after infection and vaccination.
Journal ArticleDOI
Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation
Stefan Barlage,Carsten Gnewuch,Gerhard Liebisch,Zsuzsanna Wolf,Franz-Xaver Audebert,Thomas Glück,D. Fröhlich,Bernhard K. Krämer,Bernhard K. Krämer,Gregor Rothe,Gerd Schmitz +10 more
TL;DR: Low apo-AI is independently related to 30-day mortality in human sepsis and the decrease in apo -AI/HDL cholesterol correlates to increased platelet activation.